September 2017 Analysis

Pages

Corporate Financing Analysis - US Pharma IPO Potential In Good Health - 25 SEPT 2017

With US IPO momentum expecting to continue accelerating and with the country's pharmaceuticals sector continuing to be forecasted as the most attractive globally, we expect the healthcare sector to continue competing for the leading share of first time domestic share sales (by deal value) going forward over the coming quarters. More broadly, with US markets sat near all-time highs and with...

READ FULL ARTICLE

Corporate Financing Analysis - Australian IPOs Showing Little Upside Potential - 18 SEPT 2017

With headwinds blowing, and with potential issuers and investors seemingly ready to wait until conditions are more favourable once more, the Australian IPO market looks set to finish 2017 with a disappointing tally of deals. Indeed, with local equities underwhelming in the face of the country's elevated housing market, and weakened commodity prices due to slowing Chinese growth, first time...

READ FULL ARTICLE

Pages